Indinavir Sulphate Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 200 mg, 400 mg
Reference Brands: Crixivan®(EU & US)
Category:
Anti Viral
Indinavir Capsules (200 mg, 400 mg), known as Crixivan® or Indivan®, are protease inhibitors used for HIV-1 treatment. Though less common today, they remain available for procurement on PharmaB2B platforms from WHO-GMP manufacturers—ideal for tenders, legacy treatment, and global HIV access programs.
Indinavir Sulphate is available in Capsules
and strengths such as 200 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Indinavir Sulphate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Indinavir Sulphate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Indinavir Sulphate Capsules, marketed under brands like Crixivan® and Indivan®, are protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 management. Available in 200 mg and 400 mg strengths, Indinavir works by inhibiting viral protease enzymes, reducing HIV replication. Though newer ARVs have largely replaced it in developed countries, Indinavir remains in use in resource-limited settings. On PharmaB2B platforms, buyers can bulk source WHO-GMP-certified generics for use in HIV programs, NGO supply chains, and public tenders. Reliable, cost-effective, and essential for legacy HIV treatment protocols, Indinavir supports access to affordable antiretroviral care worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing